Nordic Bioscience & Roche Bolster Collab to Develop Biomarkers for Chronic Diseases
Nordic Bioscience is collaborating with Roche for the development of proprietary biomarkers involved in tissue breakdown and build-up.
Read MorePosted by Andy Lundin | Jun 17, 2022 | Company News, Diagnostic Technologies |
Nordic Bioscience is collaborating with Roche for the development of proprietary biomarkers involved in tissue breakdown and build-up.
Read MorePosted by Andy Lundin | Jun 15, 2022 | Sequencing Systems |
Acutis Diagnostics, a New York State laboratory, is developing advanced gene sequencing technologies that can be used in the clinic.
Read MorePosted by Andy Lundin | Jun 14, 2022 | Infectious Diseases |
A study found that the rate of hepatitis C antibody screening is low, with nearly 41% of pregnant people receiving screening in early 2021.
Read MorePosted by Chris Wolski | Jun 10, 2022 | Covid 19 |
Analyzing SARS-CoV-2 samples from university screening programs, allowed researchers to gather critical data about the Omicron variant.
Read MorePosted by Andy Lundin | Jun 9, 2022 | Covid 19, Molecular Diagnostics |
LumiraDx achieved CE Mark for two new molecular tests, the Dual-Target SARS-CoV-2 STAR Complete and SARS-CoV-2 & Flu A/B RNA STAR Complete.
Read More